Neo Ivy Capital Management Has $1.34 Million Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Neo Ivy Capital Management raised its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 26,132.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 182,052 shares of the company's stock after acquiring an additional 181,358 shares during the period. Neo Ivy Capital Management's holdings in LifeStance Health Group were worth $1,341,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. Jennison Associates LLC raised its position in shares of LifeStance Health Group by 278.4% in the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock worth $59,597,000 after buying an additional 5,949,438 shares during the period. Dimensional Fund Advisors LP increased its holdings in LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock valued at $25,977,000 after buying an additional 1,643,390 shares during the last quarter. Vanguard Group Inc. increased its holdings in LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock valued at $78,781,000 after buying an additional 784,818 shares during the last quarter. First Trust Advisors LP acquired a new position in LifeStance Health Group in the fourth quarter valued at approximately $4,535,000. Finally, First Eagle Investment Management LLC boosted its stake in LifeStance Health Group by 182.8% in the fourth quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock valued at $5,790,000 after acquiring an additional 507,826 shares during the period. 85.50% of the stock is currently owned by institutional investors and hedge funds.

LifeStance Health Group Stock Down 2.1%

Shares of LifeStance Health Group stock traded down $0.13 on Thursday, hitting $5.92. 712,594 shares of the company traded hands, compared to its average volume of 1,585,610. The company has a 50-day moving average price of $6.35 and a 200 day moving average price of $7.15. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The company has a market cap of $2.30 billion, a PE ratio of -22.90 and a beta of 1.30.

Insider Buying and Selling

In related news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 3.20% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. UBS Group raised LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a report on Tuesday. Canaccord Genuity Group assumed coverage on LifeStance Health Group in a report on Thursday, April 3rd. They set a "buy" rating and a $8.00 target price on the stock. William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. Finally, KeyCorp started coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target on the stock. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, LifeStance Health Group currently has a consensus rating of "Moderate Buy" and an average price target of $8.50.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.